Literature DB >> 33643380

Coupling of Co-expression Network Analysis and Machine Learning Validation Unearthed Potential Key Genes Involved in Rheumatoid Arthritis.

Jianwei Xiao1, Rongsheng Wang2, Xu Cai1, Zhizhong Ye1.   

Abstract

Rheumatoid arthritis (RA) is an incurable disease that afflicts 0.5-1.0% of the global population though it is less threatening at its early stage. Therefore, improved diagnostic efficiency and prognostic outcome are critical for confronting RA. Although machine learning is considered a promising technique in clinical research, its potential in verifying the biological significance of gene was not fully exploited. The performance of a machine learning model depends greatly on the features used for model training; therefore, the effectiveness of prediction might reflect the quality of input features. In the present study, we used weighted gene co-expression network analysis (WGCNA) in conjunction with differentially expressed gene (DEG) analysis to select the key genes that were highly associated with RA phenotypes based on multiple microarray datasets of RA blood samples, after which they were used as features in machine learning model validation. A total of six machine learning models were used to validate the biological significance of the key genes based on gene expression, among which five models achieved good performances [area under curve (AUC) >0.85], suggesting that our currently identified key genes are biologically significant and highly representative of genes involved in RA. Combined with other biological interpretations including Gene Ontology (GO) analysis, protein-protein interaction (PPI) network analysis, as well as inference of immune cell composition, our current study might shed a light on the in-depth study of RA diagnosis and prognosis.
Copyright © 2021 Xiao, Wang, Cai and Ye.

Entities:  

Keywords:  WGCNA; artificial intelligence; diagnosis; machine learning; prognosis; rheumatoid arthritis

Year:  2021        PMID: 33643380      PMCID: PMC7905311          DOI: 10.3389/fgene.2021.604714

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  67 in total

1.  The Bin1 gene localizes to human chromosome 2q14 by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization.

Authors:  D Negorev; H Riethman; R Wechsler-Reya; D Sakamuro; G C Prendergast; D Simon
Journal:  Genomics       Date:  1996-04-15       Impact factor: 5.736

2.  Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.

Authors:  Meilang Xue; Kelly McKelvey; Kaitlin Shen; Nikita Minhas; Lyn March; Sang-Youel Park; Christopher J Jackson
Journal:  Rheumatology (Oxford)       Date:  2014-06-29       Impact factor: 7.580

3.  Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data.

Authors:  Dana E Orange; Phaedra Agius; Edward F DiCarlo; Nicolas Robine; Heather Geiger; Jackie Szymonifka; Michael McNamara; Ryan Cummings; Kathleen M Andersen; Serene Mirza; Mark Figgie; Lionel B Ivashkiv; Alessandra B Pernis; Caroline S Jiang; Mayu O Frank; Robert B Darnell; Nithya Lingampali; William H Robinson; Ellen Gravallese; Vivian P Bykerk; Susan M Goodman; Laura T Donlin
Journal:  Arthritis Rheumatol       Date:  2018-04-02       Impact factor: 10.995

4.  BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.

Authors:  D Sakamuro; K J Elliott; R Wechsler-Reya; G C Prendergast
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

5.  The role of interleukin 6 in the pathophysiology of rheumatoid arthritis.

Authors:  Srinivasan Srirangan; Ernest H Choy
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

6.  Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.

Authors:  R Wechsler-Reya; D Sakamuro; J Zhang; J Duhadaway; G C Prendergast
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

7.  Genetic variations in ZFP36 and their possible relationship to autoimmune diseases.

Authors:  Danielle Mercatante Carrick; Patricia Chulada; Rachelle Donn; Martina Fabris; Janet McNicholl; William Whitworth; Perry J Blackshear
Journal:  J Autoimmun       Date:  2006-03-20       Impact factor: 7.094

8.  α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis.

Authors:  Huili Wang; Maria Morales-Levy; Jason Rose; Lantz C Mackey; Peter Bodary; Daniel Eitzman; Jonathon W Homeister
Journal:  Am J Pathol       Date:  2013-04-02       Impact factor: 4.307

9.  Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis.

Authors:  Jun Li; Hui-Chen Hsu; Yana Ding; Hao Li; Qi Wu; PingAr Yang; Bao Luo; Amber L Rowse; David M Spalding; S Louis Bridges; John D Mountz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

Review 10.  The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.

Authors:  M Feldmann
Journal:  J R Coll Physicians Lond       Date:  1996 Nov-Dec
View more
  3 in total

1.  Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets.

Authors:  Ahmed B Alarabi; Attayeb Mohsen; Kenji Mizuguchi; Fatima Z Alshbool; Fadi T Khasawneh
Journal:  BMC Med Genomics       Date:  2022-04-14       Impact factor: 3.622

2.  Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.

Authors:  Prakash Jha; Prithvi Singh; Shweta Arora; Armiya Sultan; Arnab Nayek; Kalaiarasan Ponnusamy; Mansoor Ali Syed; Ravins Dohare; Madhu Chopra
Journal:  J Cell Biochem       Date:  2022-01-17       Impact factor: 4.480

Review 3.  Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review.

Authors:  Sara Momtazmanesh; Ali Nowroozi; Nima Rezaei
Journal:  Rheumatol Ther       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.